Occurrence of thyroxine tablet (Thyradin S®) - induced liver dysfunction in a patient with subclinical hypothyroidism

A 54-year-old woman with subclinical hypothyroidism developed liver dysfunction after increasing dose of levothyroxine (L-T4) in tablet form (Thyradin S®) from 25μg to 50μg. Viral hepatitis, autoimmune hepatitis and NASH were ruled out with examinations. After cessation of levothyroxine in 50μg tabl...

Full description

Saved in:
Bibliographic Details
Published inEndocrine Journal Vol. 62; no. 8; pp. 719 - 724
Main Authors Kang, Shino, Amino, Nobuyuki, Kudo, Takumi, Nishihara, Eijun, Ito, Mitsuru, Hirokawa, Mitsuyoshi, Miyauchi, Akira, Tamada, Daisuke, Yasuda, Takenori
Format Journal Article
LanguageEnglish
Published Japan The Japan Endocrine Society 2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A 54-year-old woman with subclinical hypothyroidism developed liver dysfunction after increasing dose of levothyroxine (L-T4) in tablet form (Thyradin S®) from 25μg to 50μg. Viral hepatitis, autoimmune hepatitis and NASH were ruled out with examinations. After cessation of levothyroxine in 50μg tablet form, liver enzymes gradually returned to normal. She was diagnosed levothyroxine-induced liver injury, based on criteria proposed in DDW-J 2004 workshop. Thyradin S® powder 0.01% (here in after referred to as L-T4 in powder form) was tried as an alternative, and liver enzymes have remained within normal range. As for Thyradin S® tablet, additives are different for each type of levothyroxine sodium content. The difference of additive is whether Fe2O3 is contained or not: it is not included in Thyradin S® 50μg tablet and powder form. Although there are two case reports in the Japanese literature and three case reports in the English literature of liver dysfunction suspected due to L-T4, we cannot find past reports about cases of drug induced liver dysfunction due to Fe2O3 free levothyroxine tablet form. This is a rare case report of drug induced liver injury due to Fe2O3 free levothyroxine tablet form, and administration of L-T4 in powder form may be useful for treatment of cases similar to this one.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0918-8959
1348-4540
DOI:10.1507/endocrj.EJ15-0112